DSCI Profile
Derma Sciences, Inc. (DSCI) was a medical technology company that focused on developing and commercializing advanced wound care products. The company was founded in 1984 and was headquartered in Princeton, New Jersey.
Derma Sciences' product portfolio included a range of wound care products, including dressings, bandages, and skin substitutes. Its solutions were designed to improve healing outcomes and reduce the risk of infection for patients with acute and chronic wounds.
In 2017, Derma Sciences was acquired by Integra LifeSciences Holdings Corporation, a medical technology company based in New Jersey, USA. The acquisition was aimed at expanding Integra's product portfolio and strengthening its position in the competitive wound care market.
As a result of the acquisition, Derma Sciences, Inc. is no longer a publicly traded company. However, its legacy continues through its contributions to the development of advanced wound care products, and through the many patients who have benefited from its solutions over the years. The acquisition also provided Derma Sciences shareholders with the opportunity to participate in the growth of Integra LifeSciences as a leading provider of medical technology solutions worldwide.
|
